These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22689975

  • 1. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.
    Kowalewski B, Lamanna WC, Lawrence R, Damme M, Stroobants S, Padva M, Kalus I, Frese MA, Lübke T, Lüllmann-Rauch R, D'Hooge R, Esko JD, Dierks T.
    Proc Natl Acad Sci U S A; 2012 Jun 26; 109(26):10310-5. PubMed ID: 22689975
    [Abstract] [Full Text] [Related]

  • 2. Decoding the consecutive lysosomal degradation of 3-O-sulfate containing heparan sulfate by Arylsulfatase G (ARSG).
    Kowalewski B, Lange H, Galle S, Dierks T, Lübke T, Damme M.
    Biochem J; 2021 Sep 17; 478(17):3221-3237. PubMed ID: 34405855
    [Abstract] [Full Text] [Related]

  • 3. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
    Trabszo C, Ramms B, Chopra P, Lüllmann-Rauch R, Stroobants S, Sproß J, Jeschke A, Schinke T, Boons GJ, Esko JD, Lübke T, Dierks T.
    Biochem J; 2020 Sep 18; 477(17):3433-3451. PubMed ID: 32856704
    [Abstract] [Full Text] [Related]

  • 4. Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.
    Kowalewski B, Lübke T, Kollmann K, Braulke T, Reinheckel T, Dierks T, Damme M.
    J Biol Chem; 2014 Oct 03; 289(40):27992-8005. PubMed ID: 25135642
    [Abstract] [Full Text] [Related]

  • 5. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation.
    Kresse H, Paschke E, von Figura K, Gilberg W, Fuchs W.
    Proc Natl Acad Sci U S A; 1980 Nov 03; 77(11):6822-6. PubMed ID: 6450420
    [Abstract] [Full Text] [Related]

  • 6. Arylsulfatases A and B in metachromatic leukodystrophy and Maroteaux-Lamy syndrome: studies with 4-methylumelliferyl sulfate.
    Kolodny EH, Mumford RA.
    Adv Exp Med Biol; 1976 Nov 03; 68():239-51. PubMed ID: 7105
    [Abstract] [Full Text] [Related]

  • 7. Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase.
    Dhamale OP, Lawrence R, Wiegmann EM, Shah BA, Al-Mafraji K, Lamanna WC, Lübke T, Dierks T, Boons GJ, Esko JD.
    ACS Chem Biol; 2017 Feb 17; 12(2):367-373. PubMed ID: 28055182
    [Abstract] [Full Text] [Related]

  • 8. Separation and properties of five glycosaminoglycan sulfatases from rat skin.
    Habuchi H, Tsuji M, Nakanishi Y, Suzuki S.
    J Biol Chem; 1979 Aug 25; 254(16):7570-8. PubMed ID: 468769
    [Abstract] [Full Text] [Related]

  • 9. Deficiencies of glucosamine-6-sulfate or galactosamine-6-sulfate sulfatases are responsible for different mucopolysaccharidoses.
    Di Ferrante N, Ginsberg LC, Donnelly PV, Di Ferrante DT, Caskey CT.
    Science; 1978 Jan 06; 199(4324):79-81. PubMed ID: 17569489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism.
    Poterala-Hejmo A, Golda A, Pacholczyk M, Student S, Tylki-Szymańska A, Lalik A.
    Int J Mol Sci; 2020 Jul 12; 21(14):. PubMed ID: 32664626
    [Abstract] [Full Text] [Related]

  • 12. Degeneration of Photoreceptor Cells in Arylsulfatase G-Deficient Mice.
    Kruszewski K, Lüllmann-Rauch R, Dierks T, Bartsch U, Damme M.
    Invest Ophthalmol Vis Sci; 2016 Mar 12; 57(3):1120-31. PubMed ID: 26975023
    [Abstract] [Full Text] [Related]

  • 13. Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).
    Kowalewski B, Heimann P, Ortkras T, Lüllmann-Rauch R, Sawada T, Walkley SU, Dierks T, Damme M.
    Hum Mol Genet; 2015 Apr 01; 24(7):1856-68. PubMed ID: 25452429
    [Abstract] [Full Text] [Related]

  • 14. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient.
    Gordon BA, Feleki V, Budreau CH, Tyler L.
    Clin Biochem; 1975 Jun 01; 8(3):184-93. PubMed ID: 238759
    [Abstract] [Full Text] [Related]

  • 15. Arylsulfatase G, a novel lysosomal sulfatase.
    Frese MA, Schulz S, Dierks T.
    J Biol Chem; 2008 Apr 25; 283(17):11388-95. PubMed ID: 18283100
    [Abstract] [Full Text] [Related]

  • 16. The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. Molecular cloning, recombinant expression, and biochemical characterization.
    Myette JR, Shriver Z, Claycamp C, McLean MW, Venkataraman G, Sasisekharan R.
    J Biol Chem; 2003 Apr 04; 278(14):12157-66. PubMed ID: 12519775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Arylsulfatases A and B in EBV-transformed lymphoid cell lines: studies on their molecular forms in cells from patients with inborn sulfatase deficiencies. Comparative diagnostic value of enzymatic assays.
    Tempesta MC, Levade T, Salvayre R.
    Clin Chim Acta; 1991 Oct 31; 202(3):149-65. PubMed ID: 1687673
    [Abstract] [Full Text] [Related]

  • 19. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J, de Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer GB, Wijburg FA, van Vlies N.
    Mol Genet Metab; 2012 Dec 31; 107(4):705-10. PubMed ID: 23084433
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N, Kida S, Kinoshita M, Morimoto H, Shibasaki T, Tachibana K, Yamamoto R.
    Mol Genet Metab; 2018 Sep 31; 125(1-2):53-58. PubMed ID: 30064964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.